Companies: 10,795·Total market cap: $144.5T
DICE Therapeutics, Inc.

DICE Therapeutics, Inc.

DICENASDAQHealthcare
$47.55
+$0.03(+0.06%)
Market Cap$2.3B
P/E Ratio
52W High$47.9
52W Low$15.08
Overview

DICE Therapeutics, Inc. (DICE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · DICE · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.19dice eps ttm · dice earnings per shareEarnings history
PE Ratio (TTM)dice pe ratio ttm · dice price to earningsPE Ratio deep dive
Revenue (TTM)0.00dice revenue ttm · dice annual revenueFull revenue history
Dividend YieldNo Dividenddoes dice pay dividends · dice dividend yieldDividend history
Shares Outstanding39.4Mdice shares outstanding · dice floatShares outstanding history
Next EarningsTBAdice earnings date · dice next earningsEarnings history

Financial Snapshot

Full Financials
FY 2022Revenue$0.00▼ 100.00% YoY
202020212022
dice therapeutics, inc. revenue · dice revenue 2022
FY 2022Net Income-$81.7M▼ 68.48% YoY
202020212022
dice therapeutics, inc. net income · dice profit 2022
FY 2022EPS$-2.07▲ +47.06% YoY
202020212022
dice eps · dice therapeutics, inc. earnings per share 2022
TTM:Revenue: $0.00Net Income: -$97.1MEPS: $-2.19View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis dice a buy · dice analyst rating
Strong Buy
0
Buy
5
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$60.00Low
$47.55Current
$60.00Avg Target26.18% upside
$60.00High
dice price target · dice 12 month forecast

Total: 10 · Buy rate: 50.0%

The DICE analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $60.00, representing +26.18% upside from the current price of $47.55.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.06%
3M+46.17%
YTD+51.77%
1Y+126.21%
5Y+28.90%

About DICE Therapeutics, Inc.

CEOJ. Kevin Judice
IPO DateSep 15, 2021
Employees71
CountryUS

DICE Therapeutics, Inc. is a biopharmaceutical firm focused on creating innovative oral drug candidates to address chronic immunological disorders and other medical conditions. The company leverages i…

what is dice therapeutics, inc. · dice stock overview · dice therapeutics, inc. company profile · who is dice therapeutics, inc. ceo · dice NASDAQ · dice therapeutics, inc. headquarters · dice therapeutics, inc. business segments

About Stock Overview & Key Data

DICE Therapeutics, Inc. (DICE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 15, 2021. As of the latest trading session, DICE stock price is $47.55, with a market capitalization of $2.3B. The stock has returned +126.21% over the past 12 months and +51.77% year-to-date.

According to 10 Wall Street analysts, the consensus rating for DICE Therapeutics, Inc. stock is Buy, with an average 12-month price target of $60.00. In fiscal year 2022, DICE Therapeutics, Inc. reported revenue of — and net income of -$81.7M. For detailed data — including DICE Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, DICE Therapeutics, Inc. (DICE) stock price is $47.55. The stock is traded on NASDAQ under the ticker symbol DICE. The 52-week range is $15.08 – $47.90.

DICE stock priceDICE quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice